These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29344607)

  • 1. Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis.
    Combalia A; Giavedoni P; Tamez L; Grau-Junyent JM; Mascaró JM
    JAMA Dermatol; 2018 Mar; 154(3):371-373. PubMed ID: 29344607
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis.
    Charrow A; Vleugels RA
    N Engl J Med; 2019 Aug; 381(5):465. PubMed ID: 31365803
    [No Abstract]   [Full Text] [Related]  

  • 3. Image Gallery: Cutaneous ulcers in anti-MDA5 dermatomyositis successfully treated with sildenafil.
    Collantes-Rodríguez C; Jiménez-Gallo D; Ossorio-García L; Villegas-Romero I; Linares-Barrios M
    Br J Dermatol; 2020 Jan; 182(1):e1. PubMed ID: 31489611
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-MDA5-Positive Dermatomyositis: A Description of the Cutaneous and Systemic Manifestations in 2 Cases.
    Barrientos N; Sicilia JJ; Moreno de Vega MJ; Dominguez JD
    Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):188-190. PubMed ID: 29162227
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-MDA5 antibody-positive bullous dermatomyositis with thyroid carcinoma.
    Hayami T; Teramura K; Tanaka T; Fujimoto N
    Eur J Dermatol; 2018 Jun; 28(3):418-419. PubMed ID: 30105998
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous ulceration in juvenile dermatomyositis with anti-melanoma differentiation-associated gene 5.
    Huang B; Huang W; Hao S
    Pediatr Dermatol; 2024; 41(2):342-343. PubMed ID: 37936561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-MDA-5-positive amyopathic dermatomyositis with cutaneous ulcerations.
    Chen Y; Teng GG; Teo WZ
    Med J Aust; 2021 Jul; 215(1):21-21.e1. PubMed ID: 34028032
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of myopathy and cutaneous ulcers in anti-MDA5-positive dermatomyositis with triple therapy.
    Peringeth G; Abbi B; Mahmood S
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38514155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin ulcers associated with dermatomyositis MDA5.
    Martínez-Díaz L; Jiménez-de la Cruz L; Moret-Rueda M; Calero-Paniagua I
    Med Clin (Barc); 2023 Feb; 160(3):143. PubMed ID: 36446651
    [No Abstract]   [Full Text] [Related]  

  • 10. Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody.
    Hasegawa A; Shimomura Y; Kibune N; Koshio J; Umemori Y; Abe R
    Clin Exp Dermatol; 2017 Jul; 42(5):551-553. PubMed ID: 28543278
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.
    De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E
    Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MDA5 dermatomyositis mimicking psoriatic arthritis.
    Cabezas-Rodríguez I; Morante-Bolado I; Brandy-García A; Queiro-Silva R; Mozo L; Ballina-García FJ
    Reumatol Clin (Engl Ed); 2018; 14(4):224-226. PubMed ID: 28040421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal septal perforation in the course of anti-MDA5 dermatomyositis.
    Theillac C; Poulalhon N; Debarbieux S; Thomas L
    Eur J Dermatol; 2016 Jun; 26(3):315-6. PubMed ID: 27033279
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharyngeal ulceration and perforation: a rare manifestation in anti-MDA5 dermatomyositis.
    Luo L; Huang W; Ren F; Zhou J; Huang D; Tang L
    Rheumatology (Oxford); 2021 Apr; 60(4):e132-e133. PubMed ID: 33197245
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases].
    Aymonier M; Abed S; Boyé T; Barazzutti H; Fournier B; Morand JJ
    Ann Dermatol Venereol; 2017 Apr; 144(4):279-283. PubMed ID: 27839728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 21-Year-Old Woman With Joint Pain and Skin Ulceration.
    French S; Lang UE; Margaretten M
    Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1553-1560. PubMed ID: 31961480
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful Treatment of Anti-MDA5 Dermatomyositis Associated Cutaneous Digital Pulp Ulcerations With Hyperbaric Oxygen Therapy.
    Jeter J; Wolf EG; Richards M; Hill E
    J Clin Rheumatol; 2020 Oct; 26(7):e266-e267. PubMed ID: 31833997
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
    Sakamoto N; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kitazaki T; Kakugawa T; Ishimatsu Y; Satoh M; Mukae H
    Intern Med; 2019 Mar; 58(6):837-841. PubMed ID: 30449789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly progressive anti-melanoma differentiation-associated protein 5 (MDA-5)-positive dermatomyositis.
    Kent RA; Venkatesh KP; Radfar A; DeKlotz CMC
    Rheumatology (Oxford); 2020 Jun; 59(6):1461. PubMed ID: 31665465
    [No Abstract]   [Full Text] [Related]  

  • 20. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
    Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.